Artificial intelligence is beginning to reshape healthcare in ways that would have seemed unrealistic just a decade ago. Hospitals are experimenting with tools that can analyze medical images in seconds, help clinicians monitor patients remotely, and even assist with clinical documentation. The market is also moving from concept to regulated reality: the U.S. Food and Drug Administration now maintains a public list of AI-enabled medical devices authorized for marketing in the United States, reflecting the growing maturity of AI in clinical and medical device environments.
While much of the attention around healthcare AI focuses on algorithms and applications, there is another important factor behind these advances: the computing infrastructure required to support them. Training and running modern AI systems requires enormous processing power, particularly when working with high-resolution imaging data or complex clinical datasets.
High-performance computing environments, particularly those built around graphics processing units (GPUs), are increasingly becoming the backbone of healthcare AI development. As these technologies mature, they are helping organizations move beyond experimentation and begin integrating AI into real clinical workflows.
In conversations with healthcare, life sciences, and MedTech organisations, we see this shift firsthand. The question is no longer simply, “Can AI work?” Increasingly, the question is, “Can we make it work securely, reliably, and at scale inside a highly regulated care environment?” That requires more than a strong model. It requires the right data architecture, cloud and edge infrastructure, cybersecurity practices, regulatory documentation, and human-centered workflow design.
Medical Imaging Is Leading the Way
One of the most visible areas of AI adoption in healthcare is medical imaging. Radiology departments produce an extraordinary amount of data each day, and interpreting those images quickly and accurately remains a critical part of patient care.
AI tools are increasingly being used to assist radiologists by highlighting abnormalities or patterns that may warrant closer attention. These systems can analyze thousands of images in a fraction of the time it would take a human reviewer, helping clinicians identify potential issues earlier. In breast cancer screening, for example, a nationwide real-world implementation study published in Nature Medicine found that AI-supported double reading was associated with a higher breast cancer detection rate without negatively affecting recall rates.
Researchers are already applying AI models to tasks such as identifying early indicators of cancer, detecting signs of cardiovascular disease, and improving the interpretation of pathology slides. A 2024 Nature study introduced a pathology foundation model designed to extract imaging features for systematic cancer evaluation, underscoring how AI may support diagnosis, prognosis, and research across multiple cancer types. The goal is not to replace clinicians, but to provide another layer of analysis that can support clinical decision-making.
The ability to train and deploy these models efficiently depends heavily on computing power. Platforms built around GPU acceleration allow developers to process large imaging datasets and run complex models that would otherwise be too slow for practical use in clinical environments.
From an implementation perspective, one lesson we have learned is that imaging AI is not only a model development challenge. It is also a workflow integration challenge. Even a highly accurate model can struggle to create value if it does not fit into how clinicians already review images, escalate findings, document results, and communicate with care teams. Infrastructure decisions therefore need to account for latency, uptime, interoperability, auditability, and the experience of the clinician who ultimately uses the tool.
Moving Toward Predictive Care
AI is also helping healthcare providers shift toward a more proactive model of care.
Traditionally, medical systems have been designed to respond to illness after symptoms appear. With the growth of predictive analytics, healthcare providers are beginning to explore how data can be used to identify risks earlier.
Machine learning models can analyze information from multiple sources, including electronic health records, hospital monitoring systems, and connected medical devices. By examining patterns across large datasets, these systems may identify warning signs that clinicians might otherwise miss.
For example, researchers have developed predictive models to flag patients who may be at risk for complications such as sepsis or hospital readmission using structured clinical data and unstructured clinical notes. A study published in Nature Communications described an AI algorithm that used both types of data to predict and diagnose sepsis, a condition where earlier recognition can be critical to patient outcomes. Johns Hopkins has also reported on an AI-enabled sepsis detection system that identified symptoms hours earlier than traditional methods and was associated with reduced mortality in hospital use. Early detection allows clinicians to intervene sooner, potentially improving outcomes while reducing costs associated with emergency care or prolonged hospital stays.
The expansion of wearable health devices and remote monitoring tools is further increasing the amount of patient data available for analysis. Processing this data in real time, however, requires robust infrastructure capable of handling continuous data streams securely, reliably and with minimal delay.
We saw this firsthand through work with a medical device startup developing a wearable sensor for nephrology clinicians to remotely monitor vital health parameters for patients with chronic and end-stage kidney disease. The device needed to collect patient data, transmit it from the wearable to a telemetry hub, and then send it to the cloud for real-time processing. Our team supported key engineering steps, including rearchitecting the system for more reliable data collection and transmission, enabling connectivity between the device and telemetry hub, and preparing documentation for FDA submission.
The project underscored an important point: predictive care depends on the full data journey. A wearable device or connected monitor is only as valuable as the system behind it: how securely data is captured, transmitted, processed, analyzed, and presented to clinicians in time to act.
Addressing a Major Operational Challenge
Not all healthcare AI innovation is focused on clinical diagnostics. In fact, one of the most immediate opportunities lies in reducing the administrative workload placed on clinicians.
Physicians often spend a significant portion of their time documenting patient encounters in electronic health record systems. These documentation requirements are essential for patient care and regulatory compliance, but they can also be time-consuming and contribute to clinician fatigue.
New AI-driven documentation tools are beginning to address this issue. Advances in speech recognition and generative AI allow software to capture physician-patient conversations, summarize key information, and generate structured clinical notes. A 2025 JAMA Network Open study noted that ambient AI platforms can listen to clinical encounters and draft documentation, with the potential to reduce administrative burden. Another JAMA Network Open qualitative study found that physicians viewed ambient AI scribes as a promising way to reduce documentation burden, while also emphasizing the importance of clinician review and responsible implementation.
Early adopters report that these tools can reduce the time required for documentation while improving the consistency of medical records. For clinicians, that may translate into more time spent with patients and less time navigating administrative systems. As these systems evolve, they may also support additional tasks such as clinical coding, summarization, and workflow automation.
However, this is also where healthcare organizations need to be careful. In our experience, the most successful AI documentation initiatives are not treated as simple software rollouts. They require governance around accuracy, privacy, consent, specialty-specific workflows, and human review. In healthcare, efficiency gains must never come at the expense of trust.
Protecting Patient Data
Any discussion of healthcare AI must also address data privacy. Patient data is among the most sensitive information handled by modern organizations, and healthcare providers operate under strict regulatory frameworks governing its use.
At the same time, developing accurate AI models often requires access to large and diverse datasets. Balancing these two realities has become a central challenge for healthcare technology developers.
One promising approach is federated learning, a method that allows AI models to be trained across multiple organizations without requiring patient data to be transferred or centralized. Instead, models learn from data stored at each participating institution, and only the model updates are shared. A review published in npj Digital Medicine describes federated learning as a potential path for digital health because it can enable collaboration across distributed data sources while reducing the need to centralize sensitive health information.
This approach allows researchers to collaborate and build stronger models while maintaining local control over sensitive data. More recently, researchers have also examined the governance mechanisms needed to make federated learning work responsibly in healthcare, including data governance, accountability, and oversight structures.
For healthcare organizations, this point is critical. AI infrastructure is not only about speed and scale. It is also about control. The organizations that succeed will be those that build data environments where privacy, security, and compliance are designed into the architecture from the beginning.
Building the Foundation for Healthcare AI
As interest in healthcare AI continues to grow, attention is increasingly shifting toward the infrastructure required to support it.
Training advanced AI models requires powerful computing environments capable of processing large volumes of data quickly. GPU-accelerated systems have become a standard component of many AI development environments, particularly in fields such as medical imaging, genomics, and connected care.
These platforms allow researchers and technology companies to experiment with more complex models and deploy them at scale. Over time, improvements in computing performance and cloud infrastructure are making these capabilities more accessible to healthcare organizations of different sizes.
But infrastructure should not be viewed only as hardware or cloud capacity. In practice, the foundation for healthcare AI includes data pipelines, integration with EHR and clinical systems, cybersecurity, model monitoring, regulatory documentation, and change management. This is especially important in MedTech environments, where software, hardware, connectivity, and compliance must come together in a product that is safe, reliable, and usable.
One lesson we have seen across healthcare and MedTech projects is that AI readiness is rarely defined by a single technology decision. It depends on whether the surrounding environment can support the model responsibly, from the way data is collected and governed to how insights are delivered into clinical workflows. A strong algorithm may generate promising results in a controlled setting, but its real-world value depends on whether it can operate securely, consistently, and transparently in the environment where care is delivered.
That distinction matters because healthcare AI cannot be separated from the systems around it. A promising model still needs to be engineered into a secure, compliant, scalable, and human-centered solution.
A Technology Still in Its Early Stages
Despite rapid progress, AI in healthcare remains in an early stage of development. Many applications are still being tested in pilot programs, and regulatory frameworks continue to evolve as the technology advances. The FDA’s ongoing work around AI and machine learning in software as a medical device reflects the need to balance innovation with patient safety, transparency, and lifecycle oversight.
Nevertheless, the direction of travel is clear. Healthcare systems around the world are searching for ways to improve efficiency, address workforce shortages, and deliver more personalized care. AI tools supported by modern computing infrastructure may play an important role in achieving those goals.
Progress will depend on collaboration between clinicians, researchers, technology developers, and regulators. As these groups continue to explore new applications for AI, the combination of advanced algorithms, high-performance computing, and secure data practices is likely to shape the next generation of healthcare innovation.
Author Bio
Pravin Tiwari, EVP and BU Head, FPT Americas
Pravin Tiwari is the Executive Vice President and Business Head at FPT Americas, a subsidiary of FPT Software, spearheading global initiatives that deliver sustainable, long-term value for customers and partners. With over two decades of senior management experience at the House of Tatas and FPT Software, Pravin has consistently driven innovation, operational excellence, and technology transformation across industries such as healthcare, media, and manufacturing.
